Presented in Table 3 are the variables of the demographic, clinical, and biochemical variables (except for data related to BMD and outcomes such as: serum levels of calcium, phosphorus, ALP) in rheumatoid arthritis patients during 15-month anti-TNF-α therapy that were obtained in our earlier investigations [28]. This evidence concerns the gene TNF and rheumatoid arthritis.